Impact of Mobile Technologies on Cervical Cancer Screening Practices in Lagos, Nigeria (mHealth-Cervix): A Randomized Controlled Trial
Authors:
- Kehinde S. OkunadeKOKehinde S. Okunade
- Adaiah Soibi-HarryASAdaiah Soibi-Harry
- Sarah John-OlabodeSJSarah John-Olabode
- Adebola A. AdejimiAAAdebola A. Adejimi
- Matthew J. AllsopMAMatthew J. Allsop
- Tonia C. OnyekaTOTonia C. Onyeka
- Godwin O. AkabaGAGodwin O. Akaba
- Yusuf A. OshodiYOYusuf A. Oshodi
- Omolola SalakoOSOmolola Salako
- Aloy O. UgwuAloy O. Ugwu
Open Access
- 23 September 2021
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 7 (7) , 1418-1425
Abstract
PURPOSE: We assessed the impact of mHealth on Pap test screening uptake and also determined the factors that affect screening uptake among women in Lagos, Nigeria. MATERIALS AND METHODS: A randomized controlled trial was carried out among women in two tertiary health institutions in Lagos, Nigeria, between July 2020 and March 2021. Participants were randomly assigned to either a text message (mHealth) intervention or usual care arm. The main study outcome was the uptake of Pap smear testing within 6 months of enrollment in the study. We tested the associations between two groups of continuous variables using the unpooled independent-sample t-test (normal distribution) and that of two groups of categorical variables with the chi-square (χ2) test. Using a multinomial logistic regression model, we adjusted for relevant sociodemographic and clinical predictors of uptake of Pap smear screening. Statistical significance was defined as P < .05. RESULTS: There was a significantly higher rate of uptake of Pap smear screening among women in the mHealth arm compared with those in the usual care arm (51.0% v 35.7%, P = .031). Following adjustment in the final multivariate model, level of income (odds ratio [OR] = 5.13, 95% CI, 1.55 to 16.95), awareness of Pap smear (OR = 16.26; 95% CI, 2.49 to 76.64), General Outpatient clinic attendance, and introduction of mHealth intervention during follow-up (OR = 4.36; 95% CI, 1.44 to 13.22) were the independent predictors of Pap smear uptake. CONCLUSION: The use of mHealth technologies intervention via short-text message services is a feasible solution for cervical cancer prevention in low- and middle-income countries, and thus, the widespread use of mHealth services by health care providers and policymakers could contribute to the implementation of cervical cancer prevention services in Nigeria and in the settings of other low- and middle-income countries.Keywords
This publication has 9 references indexed in Scilit:
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesCA: A Cancer Journal for Clinicians, 2021
- Innovative Use of mHealth and Clinical Technology for Oncology Clinical Trials in AfricaJCO Global Oncology, 2020
- Impact of mobile technologies on cervical cancer screening practices in Lagos, Nigeria (mHealth-Cervix): Protocol for a randomised controlled trialF1000Research, 2020
- Women's knowledge of cervical cancer and uptake of Pap smear testing and the factors influencing it in a Nigerian tertiary hospitalJournal of Cancer Research and Practice, 2018
- Knowledge and Acceptability of Human Papillomavirus Vaccination among Women Attending the Gynaecological Outpatient Clinics of a University Teaching Hospital in Lagos, NigeriaJournal of Tropical Medicine, 2017
- Knowledge, practice, and barriers toward cervical cancer screening in Elmina, Southern GhanaInternational Journal of Women's Health, 2014
- Awareness and uptake of the Pap smear among market women in Lagos, NigeriaJournal of Public Health in Africa, 2011
- European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1Cytopathology, 2008
- Socioeconomic Status in Relation to Obesity and Abdominal Obesity in Korean Adults: A Focus on Sex DifferencesObesity, 2006